Skip to main
ZEAL
ZEAL logo

Zealand Pharma (ZEAL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Zealand Pharma (ZEAL) Stock

About Zealand Pharma (ZEAL)

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
Market cap$814.08M
Today's volume
Revenue (TTM)$8.01M
Avg. daily volume2.31K
EBITDA (TTM)-$197.48M
Open
Price / earnings ratio-4.51x
Today's range
Debt / equity4.75x
52 week range$9.93 - $32.94
5 year debt / equity
Beta (LTM)0.77x
Interest coverage-31.03x
Dividend & yield$0.00 (0.00%)
Current ratio25.1x
Ex-dividend date
Next earningsMay 11, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 11, 2025, the market cap for ZEAL stock is $814.09M

The current P/E ratio for ZEAL stock is -4.51

The 52-week high for ZEAL stock is $32.94. The current ZEAL stock price $undefined is 100.00% below its 52-week high

The 52-week low for ZEAL stock is $9.93. The current ZEAL stock price $undefined has increased 100.00% from its 52-week low

No, the ZEAL stock does not pay dividends to its shareholders

How to buy ZEAL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ZEAL stock

    Navigate to the Explore page. Then, type ZEAL into the search bar. When you see ZEAL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ZEAL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Zealand Pharma Stock Earnings

The value each ZEAL share was expected to gain vs. the value that each ZEAL share actually gained.

Zealand Pharma (ZEAL) reported Q2 2022 earnings per share (EPS) of -$1.40, missing estimates of -$0.70 by 100.00%. In the same quarter last year, Zealand Pharma's earnings per share (EPS) was -$1.11. Zealand Pharma is expected to release next earnings on 05/11/2023, with an earnings per share (EPS) estimate of $0.

Buy Zealand Pharma (ZEAL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.